A Critical Review on SARS-CoV-2: Nature or Nurture?
Emmanuel Chigozie Udegbunam, Christian Chibuzo Uba, Okwunna Onyekachi Ikwuazom, Thomas Emmanuel Kanai, Joy Ogugua Igwe, Ogadinma Daughter Okengwu
Annual Research & Review in Biology · pp. 148–158 · Published 26 Jun 2025
10.9734/arrb/2025/v40i62262Abstract
SARS-CoV-2 belongs to the family of coronaviridae and genus coronavirus and is the causative agent of COVID-19 disease that originated in Wuhan, China, a disease characterized by shortness of breath, severe fever, and cough. Scientists continue to be divided as to the origin of the virus with some scientists proposing the emergence of the SARS-CoV-2 as a consequence of evolutionary mutation, implicating the Bat corona virus as a possible ancestor while some scientists propose a laboratory leak and a possible consequence of a laboratory creation. This is further complicated because of the unique polybasic sequence at the furin cleavage site within the S1/S2 spike protein, a characteristic not found in any close family of the SARS-CoV-2, but found in its distant relatives. While the origins of SARS-CoV-2 continue to be a subject of debate, this review is an attempt on the presentation of facts that may give clues as to the origin of the virus and a call for extensive research on the repurposing of drugs apart from Ivermectin and hydroxychloroquine which may be beneficial among low and middle income populations.
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.